Vaxcyte, Inc. (PCVX) SEC Filings & Financial Intelligence
Vaxcyte, Inc. (PCVX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PCVX
CIK: 1649094
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerKelsey Yuan
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-11-06 | — | SCHEDULE 13G/A Filing | 0001897612-26-000705 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-11-06 | — | SCHEDULE 13G/A Filing | 0001897612-26-000700 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001960048-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001813798-26-000025 | View SEC Doc Filr Page |
| 10-Q | 2026-11-04 | 2026-09-30 | 10-Q | 0001649094-26-000054 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001649094-26-000051 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001969223-26-001117 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001969223-26-001113 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-06 | 8-K | 0001193125-26-419174 | View SEC Doc Filr Page |
| 424B5 | 2026-10-08 | — | 424B5 | 0001193125-26-417984 | View SEC Doc Filr Page |
| 424B5 | 2026-10-08 | — | 424B5 | 0001193125-26-417977 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001813798-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001960048-26-000013 | View SEC Doc Filr Page |
| FWP | 2026-10-07 | — | FWP | 0001193125-26-416132 | View SEC Doc Filr Page |
| 305B2 | 2026-10-06 | — | 305B2 | 0001193125-26-414780 | View SEC Doc Filr Page |
| 424B5 | 2026-10-06 | — | 424B5 | 0001193125-26-414774 | View SEC Doc Filr Page |
| 424B5 | 2026-10-06 | — | 424B5 | 0001193125-26-414772 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001969223-26-001059 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001969223-26-001058 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001193125-26-413168 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001813798-26-000021 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001969223-26-001049 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001258693-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001230724-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001886794-26-000012 | View SEC Doc Filr Page |